Whose Body is It Anyway?
Doesn’t appeal to you, does it?
Would you like to turn over handle of your wellness and viability – possibly your really longevity – to an understaffed, underfunded government bureaucracy?
Doesn’t appeal to you, does it?
The FDA (U.S. Food & Drug Administration), which if you assume about it for a little although, has extraordinary energy over your private properly-becoming – may achieve even far more dominance more than your destiny. The battle for world domination of your body will happen this fall in the august chambers of the U.S. Supreme Court.
The foundation of the legal fight is the Vermont Supreme Court selection in Levine v. Wyeth.
Diana Levine, an expert musician, was treated, in April 2000, for a serious migraine headache and nausea. Staff at the Vermont Well being Center injected her with Phenergan, a nausea medication. They employed her arm to administer the injection and the outcome was really disastrous: she lost her appropriate arm below the elbow, and left the hospital an amputee.
Levine sued Wyeth, which sells Phenergan, on the basis that the warning label on Phenergan – even though it complied with FDA specifications – was inadequate. Levine won a jury trial and was awarded about $6.8 million.
Wyeth appealed the selection since it wants to hide behind the FDA. The situation went to the Vermont Supreme Court which ruled against Wyeth, saying, in essence, the drug manufacturer had a duty beneath state law to strengthen the warning label on the drug, regardless of the FDA’s confusing, and sometime conflicting, regulations on when, or if, warning labels ought to be revised.
The Politics of Pre-Emption
At the heart of the upcoming U.S. Supreme Court battle is the idea of pre-emption: that federal law pre-empts the proper of victims such as Diana Levine to sue for the damages inflicted upon them in state courts.
The [supposed] logic is this: if the FDA has authorized the drug, or healthcare device, and the label, then drug manufacturers need only to comply with the FDA’s requirements to be granted sweeping immunity against personal injury law suits filed in state court for damages based for failure to warn. Or as the New York Instances stated the drug firms are hunting for “a legal shield” against becoming held accountable.
Why is it that key corporations, and a lot of of their Republican supporters, are always talking about accountability and responsibility, until it comes to them?
The whole factor is scary.
Right here is an agency – the FDA – which is understaffed and not maintaining up with technology – faced with the possibility of assuming even far more control over our quite being. USA These days published a story – citing an independent panel assessment of the FDA – which revealed that the agency has about the very same size staff as 15 years ago. According to the article, As an alternative of getting proactive, the agency (FDA) is often in “fire-fighting” mode.
If the U.S. Supreme Court guidelines in favor of Wyeth, upholding the pre-emption rule, it requires away one of the key legal remedies the typical U.S. citizen has when events such as Diana Levine’s nightmare happens.
And yes, politics, notably the Bush administration, is solidly evident. The Bush Administration has moved stealthily to stop state widespread law claims.
In January 2006, the FDA adopted new regulations, the ultimate purpose was to torpedo efforts to allow individual injury claims to be heard by state court juries.
The FDA stated “it is the specialist federal public agency charged by Congress with insuring that drugs are safe and successful and that their labeling adequately informs customers of the risks and rewards of the item and is truthful and not misleading.” Translation: “if we say it won’t kill you, it will not kill you.”
And because when is the FDA in the job of insuring something? These are the same people who can even inspect imported food to make positive it is secure.
Take all the extremely technical legal argument out of this and there is nonetheless the aspect of human error, of an understaffed agency monitoring an exponentially developing quantity of pharmaceutical goods, and the possible for this agency to slam the door in a citizen’s face ought to a medical catastrophe happen.
In May possibly, the Congressional Committee on Oversight and Government Reform held hearings on the pre-emption issue. Chairman, Rep. Henry Waxman, said in his statement, that if the pharmaceutical managers, the FDA and the Bush Administration have their way in court, “…one particular of the most powerful incentives for safety, the threat of liability, would vanish.”
Whose body is it anyway? Yours, or the FDA’s?
Onward.
Richard Alexander
To know more about it, please go to: rent lawyer internet marketing





Recent Comments